Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Cantor Fitzgerald
US Department of Justice
Mallinckrodt
Accenture
Colorcon
Federal Trade Commission
Johnson and Johnson

Generated: December 17, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SINGULAIR

« Back to Dashboard

Clinical Trials for Singulair

Trial ID Title Status Sponsor Phase Summary
NCT00115297 Montelukast for Early Life Wheezing Active, not recruiting National Heart, Lung, and Blood Institute (NHLBI) Phase 2/Phase 3 This study will determine the effects of montelukast on the duration of wheezing in children 12 months to 3 years of age who visit a physician for care of a wheezing illness. Only patients from the Ankara area of Hacettepe University Medical Center in Turkey will be included in this study.
NCT00115297 Montelukast for Early Life Wheezing Active, not recruiting University of Massachusetts, Worcester Phase 2/Phase 3 This study will determine the effects of montelukast on the duration of wheezing in children 12 months to 3 years of age who visit a physician for care of a wheezing illness. Only patients from the Ankara area of Hacettepe University Medical Center in Turkey will be included in this study.
NCT00119015 The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis Terminated Merck Sharp & Dohme Corp. Phase 4 Some people with nasal allergy symptoms continue to have symptoms even after treatment with a nasal steroid spray. The purpose of this study is to see if these patients are helped by adding another medication (montelukast) to their treatment compared to placebo (a substance that looks like the active medication but does not contain the drug).
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Singulair

Condition Name

Condition Name for Singulair
Intervention Trials
Asthma 40
Healthy 14
Eosinophilic Esophagitis 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Singulair
Intervention Trials
Asthma 30
Rhinitis 11
Rhinitis, Allergic 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Singulair

Trials by Country

Trials by Country for Singulair
Location Trials
United States 90
India 10
United Kingdom 7
Canada 5
Korea, Republic of 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Singulair
Location Trials
North Carolina 5
North Dakota 4
California 4
Texas 4
Indiana 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Singulair

Clinical Trial Phase

Clinical Trial Phase for Singulair
Clinical Trial Phase Trials
Phase 4 29
Phase 3 8
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Singulair
Clinical Trial Phase Trials
Completed 64
Unknown status 10
Active, not recruiting 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Singulair

Sponsor Name

Sponsor Name for Singulair
Sponsor Trials
Merck Sharp & Dohme Corp. 22
Dr. Reddy's Laboratories Limited 6
GlaxoSmithKline 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Singulair
Sponsor Trials
Other 60
Industry 59
NIH 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Dow
AstraZeneca
Deloitte
Daiichi Sankyo
Johnson and Johnson
Farmers Insurance
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.